PT98955B - Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao - Google Patents
Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao Download PDFInfo
- Publication number
- PT98955B PT98955B PT98955A PT9895591A PT98955B PT 98955 B PT98955 B PT 98955B PT 98955 A PT98955 A PT 98955A PT 9895591 A PT9895591 A PT 9895591A PT 98955 B PT98955 B PT 98955B
- Authority
- PT
- Portugal
- Prior art keywords
- water
- granulation
- dry
- stabilizer
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Lubricants (AREA)
- Developing Agents For Electrophotography (AREA)
Description
dor Gral de 10 1 de elevada tensão de | corte com as | seguintes |
formulações, respectivamente: FORMULAÇÃO | 3 (Kq) | 5 & 6 (kq) |
mianserina.HC1 | 10 | 10 |
amido de batata (intragranular) | 7,5 | 7,5 |
amido de batata (intergranular) | 2,5 | 2,5 |
metilcelulose | 1 | 1 |
Na4P20y | - | 3 |
dióxido de silício coloidal | 2 | 2 |
estearato de magnésio | 0,6 | 0,6 |
di-hidrato de fosfato de cálcio dibásico | qbp 100,0 | 100,0 |
Claims (9)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58185990A | 1990-09-13 | 1990-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT98955A PT98955A (pt) | 1992-08-31 |
PT98955B true PT98955B (pt) | 1999-02-26 |
Family
ID=24326864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98955A PT98955B (pt) | 1990-09-13 | 1991-09-12 | Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0475482B1 (pt) |
JP (1) | JP3153577B2 (pt) |
KR (1) | KR100196209B1 (pt) |
AT (1) | ATE112491T1 (pt) |
AU (1) | AU643920B2 (pt) |
CA (1) | CA2049811C (pt) |
DE (1) | DE69104453T2 (pt) |
DK (1) | DK0475482T3 (pt) |
ES (1) | ES2064887T3 (pt) |
FI (1) | FI104361B (pt) |
IE (1) | IE65274B1 (pt) |
NZ (1) | NZ239753A (pt) |
PT (1) | PT98955B (pt) |
ZA (1) | ZA916661B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6428894A (en) * | 1993-03-26 | 1994-10-24 | Franciscus W.H.M. Merkus | Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
JP2001518923A (ja) * | 1997-03-26 | 2001-10-16 | ダブリュ エイチ エム マーカス,フランシスカス | 鼻腔用メラトニン組成物 |
GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
US6691057B2 (en) | 2001-02-26 | 2004-02-10 | L.U.M. Gesellschaft Fur Labor- Umweltdiagnostic & Medizintechnik Mbh | Method and device for accelerated stability analysis |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
CA2873524C (en) | 2006-05-04 | 2018-02-20 | Boehringer Ingelheim International Gmbh | A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
BRPI0923121A2 (pt) | 2008-12-23 | 2015-08-11 | Boehringer Ingelheim Int | Formas salinas de compostos orgânico |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
CN102753161A (zh) | 2009-11-27 | 2012-10-24 | 贝林格尔.英格海姆国际有限公司 | 基因型糖尿病患者利用dpp-iv抑制剂例如利拉利汀的治疗 |
WO2011138421A1 (en) | 2010-05-05 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Combination therapy |
EP3124041A1 (en) | 2010-06-24 | 2017-02-01 | Boehringer Ingelheim International GmbH | Diabetes therapy |
AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
ES2713566T3 (es) | 2011-07-15 | 2019-05-22 | Boehringer Ingelheim Int | Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
RU2609198C1 (ru) * | 2016-01-25 | 2017-01-30 | Закрытое Акционерное Общество "БИОКОМ" | Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения |
JP2019517542A (ja) | 2016-06-10 | 2019-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | リナグリプチンおよびメトホルミンの組合せ |
KR102416406B1 (ko) * | 2019-09-24 | 2022-07-04 | 주식회사 종근당 | 티카그렐러의 산 부가염을 포함하는 안정화된 약학 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2554736A (en) | 1951-05-29 | Tertiary aminoalkyl-iminodibenzyls | ||
US2018410A (en) | 1933-12-11 | 1935-10-22 | Victor Chemical Works | Dentifrice preparation |
US2287699A (en) | 1940-02-15 | 1942-06-23 | Monsanto Chemicals | Stabilized dicalcium phosphate |
US3012852A (en) | 1956-06-06 | 1961-12-12 | Monsanto Chemicals | Stabilized calcium phosphates and process therefor |
DE1277222B (de) | 1965-12-22 | 1968-09-12 | Knapsack Ag | Verfahren zur Stabilisierung von Dicalciumphosphatdihydrat |
NL129434C (pt) | 1966-03-12 | |||
US4128641A (en) | 1975-07-31 | 1978-12-05 | Hzi Research Center Inc. | Tetracyclic psychotropic drug |
DE2648061C2 (de) | 1976-10-23 | 1982-11-04 | Hoechst Ag, 6000 Frankfurt | Verfahren zum Stabilisieren von Di-calciumhydrogenphosphatdihydrat |
DE2741513A1 (de) | 1977-09-15 | 1979-03-22 | Benckiser Gmbh Joh A | Verfahren zum stabilisieren von calciumhydrogenphosphat-dihydrat gegen hydrolyse |
IE52274B1 (en) | 1980-12-12 | 1987-09-02 | Stauffer Chemical Co | A process of compacting fine particles of calcium phosphate and the compacts obtained thereby |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
US4743450A (en) | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
US5004651A (en) | 1989-01-24 | 1991-04-02 | Abbott Laboratories | Stabilizing system for solid dosage forms |
GB8920693D0 (en) * | 1989-09-13 | 1989-10-25 | Nicholas Kiwi Pty Ltd | Non-effervescent ibuprofen compositions |
-
1991
- 1991-08-13 DE DE69104453T patent/DE69104453T2/de not_active Expired - Lifetime
- 1991-08-13 EP EP91202070A patent/EP0475482B1/en not_active Expired - Lifetime
- 1991-08-13 AT AT91202070T patent/ATE112491T1/de not_active IP Right Cessation
- 1991-08-13 DK DK91202070.8T patent/DK0475482T3/da active
- 1991-08-13 ES ES91202070T patent/ES2064887T3/es not_active Expired - Lifetime
- 1991-08-22 ZA ZA916661A patent/ZA916661B/xx unknown
- 1991-08-23 CA CA002049811A patent/CA2049811C/en not_active Expired - Fee Related
- 1991-08-27 AU AU83416/91A patent/AU643920B2/en not_active Expired
- 1991-08-29 IE IE305491A patent/IE65274B1/en not_active IP Right Cessation
- 1991-09-03 FI FI914147A patent/FI104361B/fi not_active IP Right Cessation
- 1991-09-11 NZ NZ239753A patent/NZ239753A/en not_active IP Right Cessation
- 1991-09-12 JP JP23322491A patent/JP3153577B2/ja not_active Expired - Fee Related
- 1991-09-12 PT PT98955A patent/PT98955B/pt not_active IP Right Cessation
- 1991-09-12 KR KR1019910015896A patent/KR100196209B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69104453T2 (de) | 1995-03-16 |
ATE112491T1 (de) | 1994-10-15 |
FI104361B (fi) | 2000-01-14 |
AU8341691A (en) | 1992-03-19 |
IE913054A1 (en) | 1992-02-25 |
AU643920B2 (en) | 1993-11-25 |
ZA916661B (en) | 1992-06-24 |
ES2064887T3 (es) | 1995-02-01 |
IE65274B1 (en) | 1995-10-18 |
EP0475482B1 (en) | 1994-10-05 |
DE69104453D1 (de) | 1994-11-10 |
NZ239753A (en) | 1992-10-28 |
JPH0578236A (ja) | 1993-03-30 |
PT98955A (pt) | 1992-08-31 |
FI914147A (fi) | 1992-03-14 |
DK0475482T3 (da) | 1995-04-03 |
KR100196209B1 (ko) | 1999-06-15 |
KR920005978A (ko) | 1992-04-27 |
FI914147A0 (fi) | 1991-09-03 |
JP3153577B2 (ja) | 2001-04-09 |
EP0475482A1 (en) | 1992-03-18 |
CA2049811C (en) | 2002-11-05 |
CA2049811A1 (en) | 1992-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT98955B (pt) | Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao | |
US5441747A (en) | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer | |
KR100348842B1 (ko) | 염기성물질로안정화된약제학적조성물 | |
US5635209A (en) | Stabilized composition of levothyroxine sodium medication and method for its production | |
US5837292A (en) | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug | |
US6153223A (en) | Stabilized pharmaceutical compositions | |
PT85213B (pt) | Processo para a preparacao de composicoes farmaceuticas de libertacao prolongada para administracao oral contendo um polimero celusosico | |
HU206265B (en) | Process for producing pharmaceutical compositions comprising morphine | |
US5322698A (en) | Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure | |
HU228958B1 (en) | Pharmaceutical preparation containing levothyroxine sodium and gelatine and their preparation | |
KR20010071765A (ko) | 제약학적 레보타이록신 제제 | |
KR0170380B1 (ko) | 고상 투여형용 안정화계 | |
EP1965773B1 (en) | Oral formulation of anhydrous olanzapine form i | |
AU743043B2 (en) | Pharmaceutical preparations of cilansetron stabilized against racemization | |
EP2833871A1 (en) | Prasugrel-containing immediate release stable oral pharmaceutical compositions | |
DE69733752T2 (de) | Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz | |
FI89455C (fi) | Foerfarande foer framstaellning av en farmaceutisk komposition | |
JPWO2007046411A1 (ja) | イソキサゾール化合物の安定化方法 | |
CA2523079C (en) | Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts | |
US20050064029A1 (en) | Stable pharmaceutical composition | |
CZ2005141A3 (cs) | Lécivý prípravek na bázi amlodipin-besilátu se zvýsenou stabilitou | |
BRPI0621867A2 (pt) | formulação estável que consiste na combinação de uma droga sensìvel à umidade e uma segunda droga, e processo para a sua fabricação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920511 |
|
FG3A | Patent granted, date of granting |
Effective date: 19981109 |
|
PC4A | Transfer of assignment |
Owner name: N.V. ORGANON, NL Effective date: 20061124 |
|
PD4A | Change of proprietorship |
Owner name: AKZO NOBEL N.V., NL Effective date: 20061124 |
|
PC4A | Transfer of assignment |
Owner name: MSD OSS B.V., NL Effective date: 20111209 |
|
PC4A | Transfer of assignment |
Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL Effective date: 20130517 |
|
PC4A | Transfer of assignment |
Owner name: MERCK SHARP & DOHME B.V., NL Effective date: 20130604 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20131111 |